Associate Professor(heuristic)Rising Star

Advanced Proteomics Techniques and Applications · Spectroscopy

Compare more Spectroscopy professors.

h-index5
i10-index3
Publications14
Citations256

Grants

15 total · 4 active

NIH #R01CA305986

Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy

Active
Amount
$600K–$700K
Period
2025-08-112030-07-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA291876

Engineering mRNA encapsulated extracellular vesicles for in vivo chimeric antigen receptor macrophage therapy for glioblastoma

Active
Amount
$600K–$700K
Period
2024-07-052029-06-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA304638

Ultrasound-guided cancer immunotherapy with targeted nanodroplets

Active
Amount
$400K–$500K
Period
2026-07-012028-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

15 total · 4 active

NIH #R01CA305986

Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy

Active
Amount
$600K–$700K
Period
2025-08-112030-07-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA291876

Engineering mRNA encapsulated extracellular vesicles for in vivo chimeric antigen receptor macrophage therapy for glioblastoma

Active
Amount
$600K–$700K
Period
2024-07-052029-06-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA304638

Ultrasound-guided cancer immunotherapy with targeted nanodroplets

Active
Amount
$400K–$500K
Period
2026-07-012028-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA284108

Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy

Active
Amount
$1M–$2M
Period
2023-08-012027-07-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #RF1NS110437

Structure of amyloid fibrils in human neurodegenerative diseases and aging

Amount
$3M–$4M
Period
2018-09-302026-08-31
PIs
3

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R01NS117828

Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody

Amount
$400K–$500K
Period
2021-06-152026-04-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01AG071177

Structural analysis of tau associated with parenchymal and vascular prion protein amyloidosis

Amount
$700K–$800K
Period
2021-04-012026-03-31
PIs
3

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #R21AG081686

Affinity purification of cross-ß fibrils using immobilized thioflavin

Amount
$200K–$300K
Period
2023-04-012026-03-31
PIs
1

Awarded at PURDUE UNIVERSITY

NIH #U24GM116789

Midwest Consortium for High Resolution Cryoelectron Microscopy

Amount
$500K–$600K
Period
2017-06-012024-05-31
PIs
11

Awarded at PURDUE UNIVERSITY

NIH #RF1AG071177

Structural analysis of tau associated with parenchymal and vascular prion protein amyloidosis

Amount
$2M–$3M
Period
2021-04-012024-03-31
PIs
3

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #F32GM139242

Understanding the effects of p97 protein-protein interactions on cellular functions using antibody-based inhibitors

Amount
<$100K
Period
2021-02-012024-01-31
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #U01NS110437

Atomic models of human tau filaments and development of tau ligands

Amount
$600K–$700K
Period
2018-09-302023-08-31
PIs
3

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #K08CA241070

A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy

Amount
$200K–$300K
Period
2021-07-012023-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA252344

Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform

Amount
$200K–$300K
Period
2020-06-012022-05-31
PIs
2

Awarded at UT SOUTHWESTERN MEDICAL CENTER

NIH #R25EY029127

Virtual Reality Augmented Hands-on Cryo-EM Training

Amount
$100K–$200K
Period
2018-05-012021-06-30
PIs
2

Awarded at PURDUE UNIVERSITY

Recent Public Signals

  1. New NIH award: Ultrasound-guided cancer immunotherapy with targeted nanodroplets2026-07-01
  2. New NIH award: Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy2025-08-11
  3. New paper: Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites (Nature Communications)2025-03-20

Rising Star

  • 9 years into career
  • 133% publication growth YoY
  • -44% citation growth YoY
  • 0% centrality growth YoY
  • 4 active grants

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0003-3248-2705

Professor Insights

Career Trajectory